B-cell targeted therapies in human autoimmune diseases: an updated perspective, Immunol Rev, vol.237, pp.264-283, 2010. ,
Atacicept in multiple sclerosis (ATAMS): a randomised, placebo-controlled, double-blind, phase 2 trial, Lancet Neurol, vol.13, pp.353-363, 2014. ,
APRIL and TALL-I and receptors BCMA and TACI: system for regulating humoral immunity, Nat Immunol, vol.1, pp.252-256, 2000. ,
ATON: results from a phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis, J Neurol Sci, vol.351, pp.174-178, 2015. ,
Treatment with atacicept enhances neuronal cell death in a rat model of optic neuritis, J Neuroimmunol, vol.268, pp.58-63, 2014. ,
BAFF AND APRIL: a tutorial on B cell survival, Annu Rev Immunol, vol.21, pp.231-264, 2003. ,
Heparan sulfate proteoglycan binding promotes APRIL-induced tumor cell proliferation, Cell Death Differ, vol.12, pp.637-648, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-02262251
Identification of proteoglycans as the APRIL-specific binding partners, J Exp Med, vol.201, pp.1375-1383, 2005. ,
BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF, Science, vol.293, pp.2108-2111, 2001. ,
Cell type-specific Nrf2 expression in multiple sclerosis lesions, Acta Neuropathol, vol.130, pp.263-277, 2015. ,
APRIL-deficient mice have normal immune system development, Mol Cell Biol, vol.24, pp.997-1006, 2004. ,
Neutrophilderived APRIL concentrated in tumor lesions by proteoglycans correlates with human B-cell lymphoma aggressiveness, Blood, vol.109, pp.331-338, 2007. ,
Developmental changes in heparan sulfate expression: in situ detection with mAbs, J Cell Biol, vol.119, pp.961-975, 1992. ,
Myelopoiesis dysregulation associated to sustained APRIL production in multiple myelomainfiltrated bone marrow, Leukemia, vol.29, pp.1901-1908, 2015. ,
Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron, Virology, vol.321, pp.332-340, 2004. ,
URL : https://hal.archives-ouvertes.fr/hal-01061438
Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow, Blood, vol.118, pp.1838-1844, 2011. ,
Review: The architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis, Neuropathol Appl Neurobiol, vol.37, pp.698-710, 2011. ,
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque, Ann Neurol, vol.78, pp.710-721, 2015. ,
Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions, J Neuropathol Exp Neurol, vol.63, pp.262-273, 2004. ,
Chondroitin sulphate proteoglycans in the central nervous system: changes and synthesis after injury, Biochem Soc Trans, vol.31, pp.335-336, 2003. ,
Control of autoimmune CNS inflammation by astrocytes, Semin Immunopathol, vol.37, pp.625-638, 2015. ,
Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor, J Neurosci, vol.19, pp.5236-5244, 1999. ,
B Cells regulate autoimmunity by provision of IL-10, Nat Immunol, vol.3, pp.944-950, 2002. ,
IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases, Nature, vol.507, pp.366-370, 2014. ,
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma, J Exp Med, vol.201, pp.195-200, 2005. ,
Accelerated central nervous system autoimmunity in BAFF-receptor-deficient mice, J Neurol Sci, vol.306, pp.9-15, 2011. ,
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis, J Neuroimmunol, vol.220, pp.104-107, 2010. ,
Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse, J Clin Immunol, vol.32, pp.1007-1011, 2012. ,
A proliferation-inducing ligand (APRIL) is expressed by astrocytes and is increased in multiple sclerosis, Scand J Immunol, vol.65, pp.92-98, 2007. ,
Albumin and multiple sclerosis, BMC Neurol, vol.16, p.47, 2016. ,
CXCL-8/IL-8 produced by diffuse large B-cell lymphomas recruits neutrophils expressing a proliferation-inducing ligand APRIL, Cancer Res, vol.77, pp.1097-1107, 2017. ,
Characterization of glycosaminoglycans produced by primary astrocytes in vitro, Glia, vol.4, pp.314-321, 1991. ,
A sulfated carbohydrate epitope inhibits axon regeneration after injury, Proc Natl Acad Sci U S A, vol.109, pp.4768-4773, 2012. ,
CS-4,6 is differentially upregulated in glial scar and is a potent inhibitor of neurite extension, Mol Cell Neurosci, vol.29, pp.545-558, 2005. ,
Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia, Eur J Neurosci, vol.21, pp.378-390, 2005. ,
Heparan sulfate proteoglycan as a plasma membrane carrier, Trends Biochem Sci, vol.28, pp.145-151, 2003. ,
Astrocytes in multiple sclerosis: a product of their environment, Cell Mol Life Sci, vol.65, pp.2702-2720, 2008. ,
Astrocytes-friends or foes in multiple sclerosis?, Glia, vol.55, pp.1300-1312, 2007. ,
Astrocytes in multiple sclerosis, Mult Scler, vol.22, pp.1114-1124, 2016. ,
Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS, J Neurosci, vol.29, pp.11511-11522, 2009. ,
Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease, Glia, vol.59, pp.166-176, 2011. ,
Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation, Nat Med, vol.20, pp.1147-1156, 2014. ,
Abnormal production of the TNF-homologue APRIL increases the proliferation of human malignant glioblastoma cell lines via a specific receptor, Oncogene, vol.23, pp.3005-3012, 2004. ,
Interleukin-10, Annu Rev Immunol, vol.11, pp.165-190, 1993. ,